ProfileGDS4718 / 207774_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 36% 35% 41% 38% 39% 37% 35% 38% 38% 38% 40% 42% 37% 44% 36% 41% 34% 38% 33% 38% 39% 36% 39% 37% 40% 35% 35% 38% 42% 41% 42% 40% 42% 36% 33% 39% 37% 40% 36% 40% 36% 41% 33% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9098138
GSM549102patient 115, normal, homogenized [OPG study]4.8114736
GSM549104patient 119, normal, homogenized [OPG study]4.7473535
GSM549108patient 138, normal, homogenized [OPG study]5.0848141
GSM549119patient 077, normal, homogenized [OPG study]4.9158238
GSM549133patient 032, cancer, homogenized [OPG study]4.9057739
GSM549139patient 042, cancer, homogenized [OPG study]4.8162137
GSM549099patient 107, normal, homogenized [OPG study]4.789335
GSM549109patient 139, normal, homogenized [OPG study]4.9212338
GSM549110patient 046, normal, homogenized [OPG study]4.9080738
GSM549114patient 063, normal, homogenized [OPG study]4.844938
GSM549122patient 082, normal, homogenized [OPG study]4.9871240
GSM549134patient 033, cancer, homogenized [OPG study]5.0825942
GSM549136patient 036, cancer, homogenized [OPG study]4.7909537
GSM549140patient 044, cancer, homogenized [OPG study]5.164744
GSM549111patient 047, normal, homogenized [OPG study]4.7573236
GSM549113patient 057, normal, homogenized [OPG study]4.9673541
GSM549132patient 031, cancer, homogenized [OPG study]4.7046734
GSM549137patient 038, cancer, homogenized [OPG study]4.8585738
GSM549142patient 047, cancer, homogenized [OPG study]4.7755833
GSM549100patient 110, normal, homogenized [OPG study]4.9158738
GSM549107patient 135, normal, homogenized [OPG study]4.8924539
GSM549115patient 068, normal, homogenized [OPG study]4.7599136
GSM549116patient 072, normal, homogenized [OPG study]4.9020539
GSM549120patient 078, normal, homogenized [OPG study]4.8414737
GSM549131patient 030, cancer, homogenized [OPG study]4.9290440
GSM549118patient 074, normal, homogenized [OPG study]4.7529935
GSM549129patient 027, cancer, homogenized [OPG study]4.7904935
GSM549123patient 088, normal, homogenized [OPG study]4.8952238
GSM549124patient 006, cancer, homogenized [OPG study]5.1350342
GSM549126patient 015, cancer, homogenized [OPG study]5.0330941
GSM549128patient 025, cancer, homogenized [OPG study]5.0781842
GSM549103patient 117, normal, homogenized [OPG study]5.0783340
GSM549117patient 073, normal, homogenized [OPG study]5.0277842
GSM549138patient 041, cancer, homogenized [OPG study]4.8005436
GSM549141patient 045, cancer, homogenized [OPG study]4.5991933
GSM549130patient 028, cancer, homogenized [OPG study]4.9449939
GSM549101patient 111, normal, homogenized [OPG study]4.8946737
GSM549105patient 128, normal, homogenized [OPG study]5.0182840
GSM549106patient 134, normal, homogenized [OPG study]4.7695236
GSM549112patient 048, normal, homogenized [OPG study]4.998940
GSM549125patient 011, cancer, homogenized [OPG study]4.8163936
GSM549127patient 024, cancer, homogenized [OPG study]5.0133441
GSM549135patient 035, cancer, homogenized [OPG study]4.60333